Micron Technologies

Micron Technologies, founded in 2000, is a prominent player in the international market, offering particle size reduction and analytical contract services in the Analytics, Biotechnology, Information Technology, Manufacturing, and Pharmaceutical industries. Operating from its headquarters in the United States, the company specializes in pharmaceutical contract micronization, milling, and analytical services with over 25 years of experience in handling pharmaceutical materials. Micron Technologies' strength lies in its ability to deliver exceptional services, combining quality, speed of response, and know-how. With two cGMP facilities, the company is strategically positioned to serve the global pharmaceutical community and has successfully passed regulatory inspections from key bodies such as the FDA, MHRA, and PMDA. Notably, Micron is renowned for its reliable technical support, offering solutions to challenges related to drug substance bioavailability and improving drug content uniformity. The company also provides specific particle sizes for inhaled drugs and conducts material characterization and stability studies. Moreover, Micron stays abreast of all regulatory issues surrounding new product development. With its strong industry presence and proven track record, Micron Technologies presents an attractive opportunity for venture capital investment, particularly for investors seeking exposure to the thriving pharmaceutical and biotechnology sectors.